These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix modulator lysyl oxidase colocalizes with amyloid-beta pathology in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis--Dutch type. Wilhelmus MM; Bol JG; van Duinen SG; Drukarch B Exp Gerontol; 2013 Feb; 48(2):109-14. PubMed ID: 23267843 [TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Attems J; Jellinger KA; Lintner F Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541 [TBL] [Abstract][Full Text] [Related]
5. Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease. Kitaguchi H; Ihara M; Saiki H; Takahashi R; Tomimoto H Neurosci Lett; 2007 May; 417(2):128-31. PubMed ID: 17403574 [TBL] [Abstract][Full Text] [Related]
6. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
7. Dystrophic neurites of senile plaques in Alzheimer's disease are deficient in cytochrome c oxidase. Pérez-Gracia E; Torrejón-Escribano B; Ferrer I Acta Neuropathol; 2008 Sep; 116(3):261-8. PubMed ID: 18629521 [TBL] [Abstract][Full Text] [Related]
8. Regression stage senile plaques in the natural course of Alzheimer's disease. Oide T; Kinoshita T; Arima K Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888 [TBL] [Abstract][Full Text] [Related]
9. Lib, transcriptionally induced in senile plaque-associated astrocytes, promotes glial migration through extracellular matrix. Satoh K; Hata M; Shimizu T; Yokota H; Akatsu H; Yamamoto T; Kosaka K; Yamada T Biochem Biophys Res Commun; 2005 Sep; 335(2):631-6. PubMed ID: 16098915 [TBL] [Abstract][Full Text] [Related]
11. Plaques of Alzheimer's disease originate from cysts of Borrelia burgdorferi, the Lyme disease spirochete. MacDonald AB Med Hypotheses; 2006; 67(3):592-600. PubMed ID: 16675154 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898 [TBL] [Abstract][Full Text] [Related]
14. Canine cognitive dysfunction and the cerebellum: acetylcholinesterase reduction, neuronal and glial changes. Pugliese M; Gangitano C; Ceccariglia S; Carrasco JL; Del Fà A; Rodríguez MJ; Michetti F; Mascort J; Mahy N Brain Res; 2007 Mar; 1139():85-94. PubMed ID: 17292335 [TBL] [Abstract][Full Text] [Related]
15. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397 [TBL] [Abstract][Full Text] [Related]
16. Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain. Zhang LH; Wang X; Stoltenberg M; Danscher G; Huang L; Wang ZY Brain Res Bull; 2008 Sep; 77(1):55-60. PubMed ID: 18639746 [TBL] [Abstract][Full Text] [Related]
17. High-throughput quantification of Alzheimer's disease pathological markers in the post-mortem human brain. Byrne UT; Ross JM; Faull RL; Dragunow M J Neurosci Methods; 2009 Jan; 176(2):298-309. PubMed ID: 18835409 [TBL] [Abstract][Full Text] [Related]
18. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology. Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347 [TBL] [Abstract][Full Text] [Related]
19. Enhancing mechanical properties of tissue-engineered constructs via lysyl oxidase crosslinking activity. Elbjeirami WM; Yonter EO; Starcher BC; West JL J Biomed Mater Res A; 2003 Sep; 66(3):513-21. PubMed ID: 12918034 [TBL] [Abstract][Full Text] [Related]
20. Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease. Shimizu H; Ghazizadeh M; Sato S; Oguro T; Kawanami O J Clin Neurosci; 2009 Feb; 16(2):277-82. PubMed ID: 19091577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]